|Category||Early Registration Rate (Register by September 21, 2023 at 23:59 GMT)||Regular Registration Rate (After September 21, 2023)||Post-Event (November 2023 – November 2024)|
|In-person Physician/Scientist (Not for profit organization)||$450||$600||N/A|
|Group In-person Physician/Scientist (this rate includes 1 in-person Physician/Scientist registration and 5 post-meeting on-demand access registrations)||$400 per person for 3+|
(If you have 10 or more please contact us)
|In-person Allied Health Professional||$350||$450||N/A|
|In-person Physician In-Training (Not for profit organization)||$350||$450||N/A|
|In-person Industry (If you work for a profit organization select this)||$600||$825||N/A|
|Post-Event On-Demand Access||$350||$350||$350|
Meeting Venue: Omni Nashville Hotel
Venue Address: 250 Rep. John Lewis Way, South, Nashville, Tennessee 37203
Follow the guidelines below to submit an abstract to IKCS: North America.
Abstract Submission Types:
Abstracts in the following categories will be considered for presentation:
Abstracts submitted in this category are Phase I-IV trials, or original research that could impact practice and standard of care. LBA Abstracts should be studies where results and conclusions are not yet available by the August 7 deadline, but will be available by the August 31, 2023 12:00 PM (Noon) PDT deadline.
Abstracts submitted in this category must have a placeholder submission (all components except for Results and Conclusions sections) received by the August 7, 2023 11:59 PM PDT abstract submission deadline.
Lead authors will receive separate instructions to complete LBA placeholder submissions by the August 31, 2023 LBA deadline.
Abstracts submitted in this category are ongoing and should not include data, results, nor conclusions.
TPS abstracts are open, enrolling, or ongoing and have not reached any protocol-specific endpoints for analysis, and consequently will only require the completion of the Background and Methods sections.
Abstracts in all phases of clinical research (I, II, III, IV) may be submitted.
TPS Abstracts, if accepted, are eligible for Poster Presentation. TPS abstracts are not eligible for Oral Presentation.
Abstracts will be reviewed by the IKCS: North America Scientific Planning Committee. Abstract notifications will be sent to lead authors in early September 2023.
Merit Award Eligibility Requirements:
The IKCS Scientific Planning Committee will select four recipients to receive a merit award for the best original submissions.
All four winners will receive a complimentary registration to IKCS 2023 North America, be recognized in the program booklet and on stage, and provided a speaking slot during the oral abstract session.
All accepted abstracts and lead authors are requested to present in-person at IKCS: North America. Accepted abstracts will be displayed at the live meeting and electronic versions will be available online for post-meeting on-demand access.
All Abstract Presenters must register for the conference.
Oral Abstract Presenter Guidelines
Abstract titles will be released on the meeting platform early October 2023.
Poster Presentations will become available beginning November 7, 2023. PDF versions of presentation slides will become available during the specific session for the presentation.
Abstract Submission Closed
Please contact [email protected].